BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Pharm Country

  Cagent Vascular Presents Positive Results from the PRELUDE Study at LINC 2018

  Dr. Andrew Holden (Auckland, New Zealand), Principal Investigator, presented 30-day and preliminary 6-month results using the FDA 510(k) cleared Serranator Alto PTA Serration Balloon Catheter at the Leipzig Interventional Course last week.

  February 7, 2018

   · 

  3 min read
• Business

  Dyadic International Announces Research and Development Collaboration to Produce An Active Ingredient in C1

  The deal will explore the potential of its C1 technology to produce an important active moiety with an integrated, global biotech company.

  February 7, 2018

   · 

  4 min read
• 

  Deals

  Coloplast Acquires IncoCare Gunhild Vieler GmbH for Undisclosed Sum

  IncoCare is a privately owned, German direct-to consumer homecare company with regional distribution of primarily continence supplies.

  February 7, 2018

   · 

  1 min read
• Business

  Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2017 Financial Results Conference Call and Webcast

  Management will host a conference call on that date at 10:00 a.m. EST to discuss these results and provide an update on the company.

  February 7, 2018

   · 

  1 min read
• Business

  Two Pharmaceutical Industry Veterans Join the Eagle Leadership Team

  Eagle, an FDA-registered and ISO-certified analytical laboratory, has expanded its leadership team with the addition of Chief Technical Officer David Hussong, PhD, and Vice President of Quality Assurance/Regulatory Affairs Mary “Mick” Moriva.

  February 7, 2018

   · 

  3 min read
• Pharm Country

  Actinium Pharmaceuticals Reminds Investors of Record Date for Rights Offering

  Record date established as February 14, 2018.

  February 7, 2018

   · 

  8 min read
• Drug Development

  Impel NeuroPharma Announces Positive Results of Phase I Clinical Trial of INP104 for Treatment of Acute Migraine Headache

  INP104 is a novel dihydroergotamine product dosed via Impel’s proprietary Precision Olfactory Delivery, or POD, intranasal delivery device.

  February 7, 2018

   · 

  3 min read
• Pluristem Issues Letter to Shareholders

  Co-CEOs, Zami Aberman and Yaky Yanay.issued the letter to shareholders.

  February 7, 2018

   · 

  9 min read
• Drug Development

  Symic Bio Completes the MODIFY2 Phase II Trial of SB-061 for the Treatment of Knee Osteoarthritis

  The 12-week, multicenter, double-blind trial of 60 patients was designed to investigate the effects of SB-061 in the overall population as well as a prespecified subpopulation of patients with knee effusions.

  February 7, 2018

   · 

  5 min read
• Drug Development

  Phosplatin Therapeutics Announces First Cohort Enrolled in Phase I / II Trial of PT-112 in Relapsed / Refractory Multiple Myeloma, and Receipt of FDA Orphan Drug Designation

  PT-112 is currently under advanced Phase I development in solid tumors.

  February 7, 2018

   · 

  3 min read